OBJECTIVES: Segmentectomy is one of the treatment options for small-sized non-small cell lung cancer (NSCLC). Although growing results support the feasibility and efficacy, it still remains unclear in segmentectomy. The International Association for the Study of Lung Cancer recommended a revised classification of TNM staging in 2009 (the seventh edition) and multidisciplinary classification of adenocarcinoma. We report here the outcome of totally thoracoscopic segmentectomy and lobectomy for T factor and adenocarcinoma.
INTRODUCTION
The Lung Cancer Study Group (LCSG) reported the results of a randomized trial that compared lobectomy and sublobar resection of the lung [1] , and showed that local recurrence rates were higher in the sublobar resection group; therefore, the standard treatment for Stage I non-small cell lung cancer (NSCLC) has been lobectomy. However, the LCSG study might have been misinterpreted because a number of wedge resections were included in the sublobar resection group. As recently reported, sublobar resection showed an equivalent outcome to lobectomy regarding the oncologic effects in small-sized NSCLC if patient selection for sublobar resection was appropriate [2] .
Video-assisted thoracic surgery (VATS) has been widespread in a variety of thoracic operations, including lung cancer. VATS is less invasive and provides benefits due to rapid post-operative recovery and shorter length of hospital stay [3] ; VATS sublobar resection as the definitive management of early stage lung cancer remains controversial and might be associated with increased local recurrence rates. Most reports related to VATS segmentectomy for early-stage NSCLC showed no significant difference in oncologic outcome compared with VATS lobectomy or open segmentectomy [2, 4] ; however, VATS segmentectomy or totally thoracoscopic segmentectomy is not widespread because the indication remains uncertain even for a small tumour, in addition to the highly complex technique.
The International Association for the Study of Lung Cancer (IASLC) recommended the seventh edition of TNM staging [5] and multidisciplinary classification of adenocarcinoma [6] . A recommended change to the T1 classification was to subclassify it into T1a (≤2 cm) and T1b (>2 to ≤ 3cm). Further, the term 'bronchioloalveolar carcinoma' (BAC) should not be used but instead adenocarcinoma in situ (AIS) for small solitary adenocarcinomas with pure lepidic growth or minimally invasive adenocarcinoma (MIA) for predominant lepidic growth with <5 mm invasion; therefore, T1 tumour and AIS or MIA, which were formerly classified as BAC, may be good candidates for segmentectomy.
Most previous reports are retrospective analyses which cannot provide definitive evidence compared with prospective randomized studies. On the basis of this limitation, propensity score analyses which may control a number of possible confounders were recommended if the retrospective data were used [7] .
The purpose of this study was to evaluate the outcome of thoracoscopic segmentectomy and thoracoscopic lobectomy on the basis of the seventh edition criteria for Stage I NSCLC by propensity analyses.
MATERIALS AND METHODS

Patients
In this retrospective study, 214 consecutive Stage IA patients underwent surgery at Oita University Hospital (Oita, Japan) between September 2003 and June 2011. The retrospective study was approved by the Institutional Review Board of our hospital. Thoracoscopic segmentectomy was performed for 90 patients and thoracoscopic lobectomy was performed for 124 patients. Both procedures were accompanied with systemic radical lymphadenectomy. The standard pre-operative evaluation and algorithm of operative assessments and procedures were described in our previous report [8] . Clinical T1 N0 M0 for segmentectomy was eligible for this retrospective analysis, and bi-or tri-segmentectomy (multi-segmentectomy) was followed when the segmental margin was <1 cm.
Post-operative pathological findings were made by two pathologists and the final staging and histology were evaluated according to the seventh edition TNM classification [5] . Patients were followed up post-operatively every 3 months by blood tests, chest X-ray and computed tomography (CT) scan at 6-month intervals. If any finding of relapse was observed, the patients underwent subsequent radiotherapy and/or chemotherapy. Re-operation was one of the options to treat local recurrence. All patients with T1b were treated by UFT (tegafur and Uracil) for 2 years.
Surgical technique
Our surgical technique is similar to previous reports [9] ; essentially, four trocars (right side operation: operator, auscultation triangle (12 mm trocar), and seventh inter-costal space of the posterior-axillary line (5 mm trocar); assistant, fourth inter-costal space (12 mm trocar) and sixth inter-costal space of the anterioraxillary line (10 mm trocar); left side operation: operator, fourth inter-costal space (12 mm trocar) and sixth inter-costal space of the anterior-axillary line (5 mm trocar); assistant, auscultation triangle (12 mm trocar) and seventh inter-costal space of the posterior-axillary line (10 mm trocar) for access and one 12 mm trocar at the seventh inter-costal space of the mid-axillary line for thoracoscope with 30°were inserted. In the cases of preoperatively undiagnosed tumour, a 12 mm operator's port was sometimes elongated to 3-4 cm for tumour palpation, grasping it by the ringed forceps for needle biopsy or wedge resection in order to confirm the intra-operative pathological diagnosis. All procedures were performed by visualization through a television monitor, so-called complete VATS or total thoracoscopy. The intrathoracic procedure for hilar and intralobar vessel treatment was the same in both procedures; however, the difference was segmental plane management by electrocautery or a stapler. Theoretically, the segmental artery is divided and ligated or stapled first, following pulmonary vein ligation, stapling or bronchus stapling. If the intra-operative examination of hilar or intralobar lymph nodes by frozen sections or real-time RT-PCR for the detection of cytokeratin-19 (CK-19) showed metastases as shown in a previous report [10] , segmentectomy was converted to lobectomy. Both procedures were followed by systemic mediastinal lymph node dissection.
Statistical analysis
All statistical analyses were performed using SPSS 14.0 (SPSS Japan Inc., Tokyo, Japan). The different variables were analysed with the χ 2 test or Fisher's exact test. Recurrence-free and overall survival was analysed using the Kaplan-Meier method and evaluated by the log-rank test. For propensity score analyses, we estimated the probability that the patients were operated by segmentectomy using logistic regression analysis. This model included variables such as age, gender, histological type, tumour size, pathological T factor and number of dissected lymph nodes. Cox regression analyses were performed for comparing the disease-free and overall survivals of patients on each procedure while adjusting for propensity score. Statistically significant differences were accepted at P < 0.05.
RESULTS
Patients and tumour characteristics are summarized in Table 1 . There were no significant differences in age, gender and histological type. Pathological T factor and tumour size were significantly different between thoracoscopic segmentectomy and lobectomy. Although all patients were clinical and pathological Stage IA, T1a was 76 of 90 (84%) in segmentectomy and 72 of 124 (58%) in lobectomy; therefore, tumour size in segmentectomy was smaller than in lobectomy. Histological type showed that the new classification of adenocarcinoma, especially AIS and MIA, was 48 (53%) in segmentectomy and 52 (42%) in lobectomy. Invasive adenocarcinoma included lepidic, acinar, papillary, solid and micropapillary subtypes. Clinical and pathological lymph node involvement in both groups was absent because of retrospective study for Stage IA. Thirty-five of non-AIS/MIA patients were evaluated by intra-operative frozen section examination for lymph node metastasis and 20 patients (7 of non-AIS/MIA and 13 of AIS/MIA) were evaluated by intra-operative real-time RT-PCR for the detection of CK-19 expression. The intra-operative evaluation of nodal involvement was not performed in 35 AIS/MIA patients because of low possibility of metastasis by pre-operative CT finding and intra-operative pathological diagnosis. None of these patients showed positive nodal metastases by frozen section in our series. Although only one patient revealed a small amount of CK-19 expression, which meant an isolated tumor cell, treatment was not converted to lobectomy because of pathological N0. As shown in Table 2 , the localization of the tumour was 46 in the right lung and 44 in the left lung. Various segmentectomies were performed for 46 single segments. Bi-, trisegmentectomies and much bigger segmentectomies combined with the adjacent segment to keep the margin >1 cm were performed for 32, 5 and 3 patients, respectively and bi-or trisegmentectomies with non-adjacent segment due to multiple cancers were performed for four cases.
The peri-operative outcome is shown in Table 3 . Mean numbers of dissected lymph nodes with segmentectomy were significantly less than with lobectomy (P < 0.0001). On the other hand, the mean blood loss and operating time in the segmentectomy group (132 ml, 257 min) were similar to the lobectomy group (202 ml, 276 min). Four cases (4.8%) were converted from thoracoscopic segmentectomy to open segmentectomy because of severe adhesion. Additionally, the duration of chest tube drainage and length of the post-operative hospital stay did not show significant differences between groups. Post-operative morbidity and mortality are summarized in Table 4 . There were no significant differences in overall morbidity between segmentectomy, 19%, and lobectomy, 23%. No mortality occurred in either group. The most common complication was prolonged air leakage longer than 7 days (10 cases in segmentectomy, 14 in lobectomy).
Local recurrence, distant metastases and cancer-related deaths are shown in Table 4 . Although 7 of 90 patients in the segmentectomy group relapsed, 7 of 124 lobectomy group patients relapsed during the follow-up period (median 30 months). In the relapsed segmentectomy patients, four (4.4%) were local recurrences and three (3.3%) were distant metastases. Only one of seven relapsed patients in the segmentectomy group had MIA and the others had adenocarcinoma or carcinosarcoma. On the other hand, four patients died due to cancer relapse in segmentectomy. Significant differences between segmentectomy and lobectomy were not found in these events (Fisher's exact test). On the basis of propensity score analyses, quintiles represented the patient groups in which all covariates were well balanced in both procedures in Stage IA patients. The analyses showed no differences in disease-free and overall survivals between two groups in entire cohort and quintiles from the lowest to the highest probability (Table 5) . Furthermore, there was no significant difference in diseasefree (Fig. 1a) and overall survival (Fig. 1b) between segmentectomy and lobectomy groups in Stage IA. In subgroup analysis, there was no significant difference in disease-free and overall survival between segmentectomy and lobectomy groups in T1a (Fig. 2a and b) and T1b ( Fig. 3a and b) . The 5-year disease-free and overall survival rates were 81 and 75% with segmentectomy, and 89 and 84% in the lobectomy group at Stage IA, respectively.
DISCUSSION
Ginsberg and Rubinstein [1] showed a 3-fold increase of local recurrence in patients who received sublobar resection; however, recent reports revealed that anatomic segmentectomy provided feasible results in the recurrence rates and overall survival if adequate selection (Stages IA and IB) was performed for NSCLC [11, 12] . The growing results support segmentectomy as one of the operative options to cure small-sized NSCLC; however, the complexity of the procedure by the thoracoscopic approach has deterred more surgeons from this procedure.
In our report, we analysed the peri-operative and oncological outcomes of thoracoscopic segmentectomy in patients with Stage IA NSCLC. Since the peri-operative outcome, including operating time, blood loss, duration of chest drainage and hospital stay did not show a difference between procedures, thoracoscopic segmentectomy may not be a challenging but rather a safe procedure to be performed by all specialist surgeons in our institute. However, at least two of them should be needed for a safety operation. The most important aspect of our technique is the five ports method, which is easier than the two or three-port methods because both operator and assistant can each use two hands in a similar fashion to thoracotomy. Therefore, it should be easily mastered by any thoracic surgeon, even if the thoracoscopic segmentectomy is a little bit challenging. The rates of peri-operative morbidity were similar between segmentectomy (19%) and lobectomy (23%). These results are comparable to previous reports, in which the mean morbidity rates were 17.6-31.3% in VATS segmentectomy and 15.3-31% in VATS lobectomy [4, 9, 13, 14] . The most frequent complication was prolonged air leakage longer than 7 days in both groups; however, segmentectomy did not increase the rates of air leakage even if we divided the segmental plane by electrocautery or stapler. These results may be due to improved sealing methods by fibrin glue and polyglycolic acid sheet [15] . Furthermore, as our results showed no operative mortality, the safety of all thoracoscopic techniques in both procedures was confirmed.
In the oncological outcome, we compared the results of recurrence rates or survival between thoracoscopic segmentectomy and lobectomy in Stage IA. Significant differences between segmentectomy and lobectomy were not found in locoregional or distant recurrence rates. The 4.4% locoregional recurrence rate was similar to previous reports [16, 17] and only one of four patients with locoregional recurrence in the segmentectomy group recurred in the ipsilateral lung even if the surgical margin was free from cancer and the histological diagnosis was AIS/MIA (formerly BAC). It is known that AIS/MIA show 100% or near 100% disease-free survival if they are completely resected [6] . The reason for recurrence was unclear but intraoperative endobronchial spread may be one of the reasons for residual lung recurrence [18] . Since only one of 100 AIS/MIA patients in both groups (1%) had recurrence, these subtypes showed favorable prognosis and were good candidates for segmentectomy; however, variants such as invasive mucinous adenocarcinoma (formerly mucinous BAC) in the new IASLC recommendation should be distinguished. Although another concern is which procedure, anatomical segmentectomy or wedge resection, is suitable for AIS/MIA, it is difficult to perform a prospective randomized control trial because of the difficulty of preoperative diagnosis of AIS/MIA. We compared the disease-free and overall survival in Stages IA, T1a and T1b, respectively. Survival rates in Stage IA showed similar results to previous reports [16, 17] . Furthermore, subanalysis of T1a showed similar disease-free and overall survival rates in both procedures. Contrary to expectations, T1b subanalysis did not show a significant difference between segmentectomy and lobectomy in spite of the similar frequency of AIS/MIA in both groups. However, small number of patients (14 segmentectomy and 52 lobectomy in T1b) may lead to elimination of the difference. Taken together, our results may support that the seventh edition classification of the T factor, especially in T1a but carefully in T1b, is applicable for patient selections of segmentectomy.
Many factors influencing the outcome of survival and local recurrence with segmentectomy have been proposed, such as lymph node dissection or sampling, and the surgical margin from the tumour [19, 20] . We performed systemic lymphadenectomy after lung resection using both procedures. The reason why the mean numbers of dissected lymph nodes in the segmentectomy group were significantly lower than in lobectomy group may be due to the number of inter-or intra-segmental nodes. Otherwise, it may be a possibility that we performed upper mediastinal node dissection without subcarinal node dissection in the cases which were located at S1-S3 segments and AIS/MIA histology in segmentectomy group.
Since VATS segmentectomy is more difficult than segmentectomy by open thoracotomy [21, 22] , it has been reported in very few papers, especially the comparison between open and VATS segmentectomy [23, 24] . The Cancer and Leukemia Group B (CALGB) 140 503, phase III trial is ongoing to compare the recurrence-free survival of patients with small tumour <2 cm in NSCLC undergoing lobectomy versus sublobar resection [25] . Also, the aim of this study was to compare the results of lobectomy by open thoracotomy to VATS or the results of sublobar resection by open thoracotomy to VATS. The results of this study will provide more precise and reliable information about the advantages or disadvantages of VATS segmentectomy.
The limitations of this study are that it involves retrospective analysis and is a single institutional study. Therefore, this study cannot provide a definitive evidence compared with randomized studies which can fully control for the distribution of important covariates among treatment groups. On the basis of this limitation, we used propensity score analyses which may control a number of possible confounders and we observed no differences between two groups in survival outcome. However, it is important to recognize that propensity score methods cannot adjust the unmeasured confounders. A Japanese trial ( JCOG0802/ WJOG4607L) comparing lobectomy and the limited resection of Stage I lung cancer will elucidate the role of segmentectomy. Another limitation is the relatively short period of follow-up to observe differences in local recurrence and overall survival between the two methods. Longer follow-up and increasing the number of patients in both groups may lead to further confirmation of the results.
In conclusion, although the sample size is small, thoracoscopic segmentectomy may be an appropriate procedure when accurate staging and careful intra-operative management are applied for Stage IA, T1a or T1b in NSCLC.
